Notice Type
Departmental
Consent to the Distribution of Changed Medicines Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Urofollitropin 75 iu Lyophilised powder for reconstitution Organon International BV, Oss, The Netherlands and Organon SA, Usine St Charles, Eragny-Sur-Epte, Serifontaine, France Puregon injection Clarithromycin 250 mg, 500 mg Tablets Abbot Australasia Pty Limited, Kurnell, New South Wales, Australia; Abbott Laboratories Limited, Queenborough, Kent, England and Abbott S.p.A., Campoverde di Aprilia, Latina, Italy Klacid Clarithromycin 125 mg/5 ml, 250 mg/5 ml Granules for reconstitution for suspension Abbot Australasia Pty Limited, Kurnell, New South Wales, Australia; Abbott Laboratories Limited, Queenborough, Kent, England and Abbott S.p.A., Campoverde di Aprilia, Latina, Italy Klacid Suspension Clarithromycin 500 mg Tablet Abbot Australasia Pty Limited, Kurnell, New South Wales, Australia; Abbott Laboratories Limited, Queenborough, Kent, England and Abbott S.p.A., Campoverde di Aprilia, Latina, Italy Maclar Terbinafine hydrochloride 125 mg, 250 mg Tablets Sandoz Pharma Limited, Basle, Switzerland Lamisil Colestipol hydrochloride 1 g. Note: This replaces the entry in the notice published in the New Zealand Gazette, 24 March 1994, No. 27, page 1176, notice number 2120. Tablet The Upjohn Company, Kalamazoo, Michigan, United States of America Colestid Morphine sulphate 10 mg, 30 mg, 60 mg, 100 mg. Note: Not to be marketed as substitutable for any other morphine sulphate product as if the two (2) products were bioequivalent. Tablets Clonmel Chemical Co Limited, Clonmel, County Tipperary, Ireland and Custom Pharmaceuticals Limited, Hove, East Sussex, England L A Morph Dated this 1st day of May 1994. A. DIXON, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
Publication Date
5 May 1994

Notice Number

1994-go3265

Page Number

1572